Cargando…

One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study

BACKGROUND: Long-term pulmonary sequelae following hospitalization for SARS-CoV-2 pneumonia is largely unclear. The aim of this study was to identify and characterise pulmonary sequelae caused by SARS-CoV-2 pneumonia at 12-month from discharge. METHODS: In this multicentre, prospective, observationa...

Descripción completa

Detalles Bibliográficos
Autores principales: Faverio, Paola, Luppi, Fabrizio, Rebora, Paola, D’Andrea, Gabriele, Stainer, Anna, Busnelli, Sara, Catalano, Martina, Modafferi, Giuseppe, Franco, Giovanni, Monzani, Anna, Galimberti, Stefania, Scarpazza, Paolo, Oggionni, Elisa, Betti, Monia, Oggionni, Tiberio, De Giacomi, Federica, Bini, Francesco, Bodini, Bruno Dino, Parati, Mara, Bilucaglia, Luca, Ceruti, Paolo, Modina, Denise, Harari, Sergio, Caminati, Antonella, Intotero, Marcello, Sergio, Pietro, Monzillo, Giuseppe, Leati, Giovanni, Borghesi, Andrea, Zompatori, Maurizio, Corso, Rocco, Valsecchi, Maria Grazia, Bellani, Giacomo, Foti, Giuseppe, Pesci, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934910/
https://www.ncbi.nlm.nih.gov/pubmed/35313890
http://dx.doi.org/10.1186/s12931-022-01994-y
_version_ 1784671930609041408
author Faverio, Paola
Luppi, Fabrizio
Rebora, Paola
D’Andrea, Gabriele
Stainer, Anna
Busnelli, Sara
Catalano, Martina
Modafferi, Giuseppe
Franco, Giovanni
Monzani, Anna
Galimberti, Stefania
Scarpazza, Paolo
Oggionni, Elisa
Betti, Monia
Oggionni, Tiberio
De Giacomi, Federica
Bini, Francesco
Bodini, Bruno Dino
Parati, Mara
Bilucaglia, Luca
Ceruti, Paolo
Modina, Denise
Harari, Sergio
Caminati, Antonella
Intotero, Marcello
Sergio, Pietro
Monzillo, Giuseppe
Leati, Giovanni
Borghesi, Andrea
Zompatori, Maurizio
Corso, Rocco
Valsecchi, Maria Grazia
Bellani, Giacomo
Foti, Giuseppe
Pesci, Alberto
author_facet Faverio, Paola
Luppi, Fabrizio
Rebora, Paola
D’Andrea, Gabriele
Stainer, Anna
Busnelli, Sara
Catalano, Martina
Modafferi, Giuseppe
Franco, Giovanni
Monzani, Anna
Galimberti, Stefania
Scarpazza, Paolo
Oggionni, Elisa
Betti, Monia
Oggionni, Tiberio
De Giacomi, Federica
Bini, Francesco
Bodini, Bruno Dino
Parati, Mara
Bilucaglia, Luca
Ceruti, Paolo
Modina, Denise
Harari, Sergio
Caminati, Antonella
Intotero, Marcello
Sergio, Pietro
Monzillo, Giuseppe
Leati, Giovanni
Borghesi, Andrea
Zompatori, Maurizio
Corso, Rocco
Valsecchi, Maria Grazia
Bellani, Giacomo
Foti, Giuseppe
Pesci, Alberto
author_sort Faverio, Paola
collection PubMed
description BACKGROUND: Long-term pulmonary sequelae following hospitalization for SARS-CoV-2 pneumonia is largely unclear. The aim of this study was to identify and characterise pulmonary sequelae caused by SARS-CoV-2 pneumonia at 12-month from discharge. METHODS: In this multicentre, prospective, observational study, patients hospitalised for SARS-CoV-2 pneumonia and without prior diagnosis of structural lung diseases were stratified by maximum ventilatory support (“oxygen only”, “continuous positive airway pressure (CPAP)” and “invasive mechanical ventilation (IMV)”) and followed up at 12 months from discharge. Pulmonary function tests and diffusion capacity for carbon monoxide (DLCO), 6 min walking test, high resolution CT (HRCT) scan, and modified Medical Research Council (mMRC) dyspnea scale were collected. RESULTS: Out of 287 patients hospitalized with SARS-CoV-2 pneumonia and followed up at 1 year, DLCO impairment, mainly of mild entity and improved with respect to the 6-month follow-up, was observed more frequently in the “oxygen only” and “IMV” group (53% and 49% of patients, respectively), compared to 29% in the “CPAP” group. Abnormalities at chest HRCT were found in 46%, 65% and 80% of cases in the “oxygen only”, “CPAP” and “IMV” group, respectively. Non-fibrotic interstitial lung abnormalities, in particular reticulations and ground-glass attenuation, were the main finding, while honeycombing was found only in 1% of cases. Older patients and those requiring IMV were at higher risk of developing radiological pulmonary sequelae. Dyspnea evaluated through mMRC scale was reported by 35% of patients with no differences between groups, compared to 29% at 6-month follow-up. CONCLUSION: DLCO alteration and non-fibrotic interstitial lung abnormalities are common after 1 year from hospitalization due to SARS-CoV-2 pneumonia, particularly in older patients requiring higher ventilatory support. Studies with longer follow-ups are needed.
format Online
Article
Text
id pubmed-8934910
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89349102022-03-21 One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study Faverio, Paola Luppi, Fabrizio Rebora, Paola D’Andrea, Gabriele Stainer, Anna Busnelli, Sara Catalano, Martina Modafferi, Giuseppe Franco, Giovanni Monzani, Anna Galimberti, Stefania Scarpazza, Paolo Oggionni, Elisa Betti, Monia Oggionni, Tiberio De Giacomi, Federica Bini, Francesco Bodini, Bruno Dino Parati, Mara Bilucaglia, Luca Ceruti, Paolo Modina, Denise Harari, Sergio Caminati, Antonella Intotero, Marcello Sergio, Pietro Monzillo, Giuseppe Leati, Giovanni Borghesi, Andrea Zompatori, Maurizio Corso, Rocco Valsecchi, Maria Grazia Bellani, Giacomo Foti, Giuseppe Pesci, Alberto Respir Res Research BACKGROUND: Long-term pulmonary sequelae following hospitalization for SARS-CoV-2 pneumonia is largely unclear. The aim of this study was to identify and characterise pulmonary sequelae caused by SARS-CoV-2 pneumonia at 12-month from discharge. METHODS: In this multicentre, prospective, observational study, patients hospitalised for SARS-CoV-2 pneumonia and without prior diagnosis of structural lung diseases were stratified by maximum ventilatory support (“oxygen only”, “continuous positive airway pressure (CPAP)” and “invasive mechanical ventilation (IMV)”) and followed up at 12 months from discharge. Pulmonary function tests and diffusion capacity for carbon monoxide (DLCO), 6 min walking test, high resolution CT (HRCT) scan, and modified Medical Research Council (mMRC) dyspnea scale were collected. RESULTS: Out of 287 patients hospitalized with SARS-CoV-2 pneumonia and followed up at 1 year, DLCO impairment, mainly of mild entity and improved with respect to the 6-month follow-up, was observed more frequently in the “oxygen only” and “IMV” group (53% and 49% of patients, respectively), compared to 29% in the “CPAP” group. Abnormalities at chest HRCT were found in 46%, 65% and 80% of cases in the “oxygen only”, “CPAP” and “IMV” group, respectively. Non-fibrotic interstitial lung abnormalities, in particular reticulations and ground-glass attenuation, were the main finding, while honeycombing was found only in 1% of cases. Older patients and those requiring IMV were at higher risk of developing radiological pulmonary sequelae. Dyspnea evaluated through mMRC scale was reported by 35% of patients with no differences between groups, compared to 29% at 6-month follow-up. CONCLUSION: DLCO alteration and non-fibrotic interstitial lung abnormalities are common after 1 year from hospitalization due to SARS-CoV-2 pneumonia, particularly in older patients requiring higher ventilatory support. Studies with longer follow-ups are needed. BioMed Central 2022-03-21 2022 /pmc/articles/PMC8934910/ /pubmed/35313890 http://dx.doi.org/10.1186/s12931-022-01994-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Faverio, Paola
Luppi, Fabrizio
Rebora, Paola
D’Andrea, Gabriele
Stainer, Anna
Busnelli, Sara
Catalano, Martina
Modafferi, Giuseppe
Franco, Giovanni
Monzani, Anna
Galimberti, Stefania
Scarpazza, Paolo
Oggionni, Elisa
Betti, Monia
Oggionni, Tiberio
De Giacomi, Federica
Bini, Francesco
Bodini, Bruno Dino
Parati, Mara
Bilucaglia, Luca
Ceruti, Paolo
Modina, Denise
Harari, Sergio
Caminati, Antonella
Intotero, Marcello
Sergio, Pietro
Monzillo, Giuseppe
Leati, Giovanni
Borghesi, Andrea
Zompatori, Maurizio
Corso, Rocco
Valsecchi, Maria Grazia
Bellani, Giacomo
Foti, Giuseppe
Pesci, Alberto
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study
title One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study
title_full One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study
title_fullStr One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study
title_full_unstemmed One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study
title_short One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study
title_sort one-year pulmonary impairment after severe covid-19: a prospective, multicenter follow-up study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934910/
https://www.ncbi.nlm.nih.gov/pubmed/35313890
http://dx.doi.org/10.1186/s12931-022-01994-y
work_keys_str_mv AT faveriopaola oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT luppifabrizio oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT reborapaola oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT dandreagabriele oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT staineranna oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT busnellisara oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT catalanomartina oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT modafferigiuseppe oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT francogiovanni oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT monzanianna oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT galimbertistefania oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT scarpazzapaolo oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT oggionnielisa oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT bettimonia oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT oggionnitiberio oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT degiacomifederica oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT binifrancesco oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT bodinibrunodino oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT paratimara oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT bilucaglialuca oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT cerutipaolo oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT modinadenise oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT hararisergio oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT caminatiantonella oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT intoteromarcello oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT sergiopietro oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT monzillogiuseppe oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT leatigiovanni oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT borghesiandrea oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT zompatorimaurizio oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT corsorocco oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT valsecchimariagrazia oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT bellanigiacomo oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT fotigiuseppe oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy
AT pescialberto oneyearpulmonaryimpairmentafterseverecovid19aprospectivemulticenterfollowupstudy